You have 9 free searches left this month | for more free features.

lonafarnib

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Delta Hepatitis Trial (lonafarnib, Ritonavir)

Completed
  • Chronic Delta Hepatitis
  • (no location specified)
Dec 12, 2022

Hepatitis D, Chronic Trial in Be'er Sheva, Auckland, Istanbul (Lonafarnib, Ritonavir)

Recruiting
  • Hepatitis D, Chronic
  • Be'er Sheva, Israel
  • +2 more
Jan 27, 2022

Liver Disease, Hepatitis D Trial run by the NIDDK (Peg-interferon lambda, Lonafarnib, Ritonavir)

Completed
  • Liver Disease
  • Hepatitis D
  • Peg-interferon lambda
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 6, 2021

Progeria, HGPS Trial (Lonafarnib)

Approved for marketing
  • Progeria
  • HGPS
  • Lonafarnib
  • (no location specified)
Apr 13, 2021

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Chronic Delta Hepatitis Trial (Lonafarnib, Ritonavir)

Withdrawn
  • Chronic Delta Hepatitis
  • (no location specified)
Feb 12, 2021

Liver Cancer Trial (gemcitabine HCl, lonafarnib, conventional surgery)

Withdrawn
  • Liver Cancer
  • gemcitabine hydrochloride
  • +2 more
  • (no location specified)
Jul 29, 2020

Hepatitis Delta Virus Trial in Worldwide (Lonafarnib, Ritonavir, PEG IFN-alfa-2a)

Recruiting
  • Hepatitis Delta Virus
  • Lonafarnib
  • +4 more
  • Fresno, California
  • +117 more
Sep 30, 2021

Progeria, Hutchinson-Gilford Syndrome Trial in Boston (Lonafarnib)

Completed
  • Progeria
  • Hutchinson-Gilford Syndrome
  • Lonafarnib
  • Boston, Massachusetts
    Children's Hospital Boston
Jun 11, 2019

Progeria, Hutchinson-Gilford Syndrome Trial in Boston (Lonafarnib, Zoledronic Acid, Pravastatin)

Completed
  • Progeria
  • Hutchinson-Gilford Syndrome
  • Lonafarnib
  • +2 more
  • Boston, Massachusetts
    Children's Hospital Boston
Jun 11, 2019

Hepatitis D Trial run by the NIDDK (Lonafarnib, Ritonavir, Placebo)

Completed
  • Hepatitis D
  • Lonafarnib
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 27, 2018

Chronic Hepatitis D Infection Trial in Ankara (lonafarnib, Ritonavir, PEG IFN-a)

Completed
  • Chronic Hepatitis D Infection
  • lonafarnib
  • +2 more
  • Ankara, Turkey
    Ankara University Medical School
Jul 27, 2017

Chronic Hepatitis D Infection Trial in Ankara (lonafarnib, PEG IFN-a, Ritonavir)

Completed
  • Chronic Hepatitis D Infection
  • lonafarnib
  • +2 more
  • Ankara, Turkey
    Ankara University Medical School
Jan 18, 2017

Hepatitis D Trial run by the NIDDK (Lonafarnib, Placebo)

Completed
  • Hepatitis D
  • Lonafarnib
  • Placebo
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 18, 2016

Metastatic Breast Cancer Trial in United States (Lonafarnib)

Terminated
  • Metastatic Breast Cancer
  • Lonafarnib
  • Galesburg, Illinois
  • +5 more
Jan 21, 2016

Brain and CNS Tumors Trial in Dijon, Nantes-Saint Herblain, Lausanne (lonafarnib, temozolomide)

Unknown status
  • Brain and Central Nervous System Tumors
  • Dijon, France
  • +2 more
Feb 9, 2015

Lymphoma, Solid Tumor Trial in New York (fluorouracil, leucovorin calcium, lonafarnib)

Completed
  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Apr 2, 2013

Lung Cancer, Soft Tissue Sarcoma, Colorectal Carcinoma Trial in Atlanta (Lonafarnib, Docetaxel)

Terminated
  • Lung Cancer
  • +4 more
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Dec 17, 2012

Breast Cancer Trial in Brussels, Paris, Amsterdam (biological, drug, other)

Completed
  • Breast Cancer
  • trastuzumab
  • +3 more
  • Brussels, Belgium
  • +2 more
Sep 11, 2012

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Nijmegen (gemcitabine HCl,

Completed
  • Bladder Cancer
  • +2 more
  • gemcitabine hydrochloride
  • lonafarnib
  • Nijmegen, Netherlands
    University Medical Center Nijmegen
Sep 20, 2012

Epithelial Ovarian Cancer Trial in Germany (Lonafarnib)

Completed
  • Epithelial Ovarian Cancer
  • Lonafarnib
  • Berlin, Germany
  • +22 more
Jun 28, 2012

Brain and CNS Tumors Trial in United States (lonafarnib)

Completed
  • Brain and Central Nervous System Tumors
  • lonafarnib
  • San Francisco, California
  • +8 more
Oct 13, 2009